Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 615.47Cr 92Cr 82Cr 76Cr 69Cr 130.86Cr 8.82TCr 132.07Cr 921.22Cr 356.97Cr 4.51TCr 344.64Cr 337.16Cr 14TCr P/E 2026 *
13.7x
P/E 2027 * 11.5x
Enterprise Value 491.59Cr 73Cr 65Cr 61Cr 55Cr 104.52Cr 7.05TCr 105.49Cr 735.8Cr 285.12Cr 3.6TCr 275.28Cr 269.3Cr 12TCr EV / Sales 2026 *
0.28x
EV / Sales 2027 * 0.25x
Free-Float
51.88%
Yield 2026 *
3.36%
Yield 2027 * 4.6%
1 day+0.75%
1 week+1.13%
1 month-4.96%
3 months+3.47%
6 months-14.24%
Current year-16.64%
1 week 10.59
Extreme 10.59
10.77
1 month 10.58
Extreme 10.58
11.38
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
14.8
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
12/05/26 Buy

Founder

13,59,000 0.3397%
12/05/26 Sell

Founder

-27,27,600 0.6818%
11/05/26 Sell

Founder

-88,06,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
+0.75%+1.13%-22.99%-53.77% 92Cr
-3.78%-1.25%-47.36%-10.49% 1.41TCr
+5.81%+7.38%+5.63%-26.66% 651.38Cr
-0.71%-3.63%-16.04%-7.02% 606.22Cr
-1.67%-4.89%-11.56%+1.08% 592.31Cr
-1.75%-0.35%-57.86%-40.86% 579.89Cr
+1.30%+5.57%-5.44%-20.24% 421.5Cr
-0.33%-0.71%-24.96%-37.89% 315.43Cr
-0.21%-1.51%-25.34%-17.88% 311.46Cr
+2.08%+3.70%+10.37%-27.63% 309.14Cr
Average +0.15%-0.50%-19.55%-24.14% 528.71Cr
Weighted average by Cap. -0.55%-0.77%-24.61%-18.72%

Financials

2026 *2027 *
Net sales 1.76TCr 262.07Cr 232.85Cr 217.32Cr 198.08Cr 373.59Cr 25TCr 377.06Cr 2.63TCr 1.02TCr 13TCr 983.93Cr 962.57Cr 41TCr 1.86TCr 277.2Cr 246.3Cr 229.88Cr 209.53Cr 395.16Cr 27TCr 398.84Cr 2.78TCr 1.08TCr 14TCr 1.04TCr 1.02TCr 44TCr
Net income 46Cr 6.8Cr 6.05Cr 5.64Cr 5.14Cr 9.7Cr 654.06Cr 9.79Cr 68Cr 26Cr 334.36Cr 26Cr 25Cr 1.07TCr 55Cr 8.15Cr 7.25Cr 6.76Cr 6.16Cr 12Cr 783.9Cr 12Cr 82Cr 32Cr 400.74Cr 31Cr 30Cr 1.29TCr
Net Debt -123.88Cr -18Cr -16Cr -15Cr -14Cr -26Cr -1.78TCr -27Cr -185.42Cr -72Cr -907.98Cr -69Cr -68Cr -2.91TCr -142.36Cr -21Cr -19Cr -18Cr -16Cr -30Cr -2.04TCr -31Cr -213.09Cr -83Cr -1.04TCr -80Cr -78Cr -3.35TCr
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
30/26/30 CN¥10.72 +0.75% 48,07,100
29/26/29 CN¥10.64 -0.37% 28,64,400
28/26/28 CN¥10.68 +0.75% 41,90,301
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
10.72CNY
Average target price
13.19CNY
Spread / Average Target
+23.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002727 Stock